Last A$0.23 AUD
Change Today +0.015 / 7.14%
Volume 618.3K
PGL On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 2:10 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Fleur Lankesheer BSc LLB

Director of Business Development & Legal, Progen Pharmaceuticals Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

--A$194,018
As of Fiscal Year 2013

Background*

Ms. Fleur Lankesheer, BSc, LLB has been Director of Business Development & Legal at Progen Pharmaceuticals Limited since June 26, 2010. Ms. Lankesheer has three years commercialisation experience as a Commercialisation Manager and Inhouse Intellectual Property Manager with Otago Innovation Ltd. She served as the Business Development Manager for a subsidiary start-up company, Immune Solutions Ltd. Ms. Lankesheer has principally been involved in new chemical and biological ...

Read Full Background

Corporate Headquarters*

2806 Ipswich Road
Darra, Queensland 4076

Australia

Phone: 61 7 3273 9133
Fax: 61 7 3375 1168

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

LLB
University of Otago
BS
University of Otago

Other Affiliations*

Annual Compensation*

SalaryA$172,698
BonusA$4,000
Total Annual CompensationA$176,698

Stock Options*

All Other CompensationA$17,320
Exercisable Options30,000
Total Number of Options30,000

Total Compensation*

Total Annual Cash CompensationA$194,018
Total Short Term CompensationA$176,698
Other Long Term CompensationA$17,320
Total Calculated CompensationA$194,018
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGL:AU A$0.23 AUD +0.015

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGEN PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.